chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood culture positive, COVID-19, Catheter removal, Chest X-ray normal, Computerised tomogram head abnormal
Clinical narrative: This is a 84y.o.male with a history of diabetes, dementia who presents sent from secondary to altered mental status with fevers. Per reports, he had an indwelling Foley catheter that was removed yesterday. After that he noted a fever of 101.7. He states he tested positive for covid around 1 month ago. He was treated with monoclonal antibodies and  since recovered. Today, he is alert and oriented ×1. He is not sure why he is in the hospital. On arrival he is afebrile. Leukocytosis of 31.6. Pro calcitonin 0.35. CT was negative for acute process but showed nonspecific white matter changes and remote left basal ganglia lacunar injuries likely related to chronic microangiopathy as well as interval right frontal lobe encephalomalacia. His CXR was negative for acute process. UA was concerning for a possible UTI. Blood cultures returned positive for gram positive cocci. Infectious disease has been consulted. He was started on cefepime/vancomycin.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Encephalomalacia, Gram stain positive, Influenza A virus test negative, Influenza B virus test, Lacunar infarction
Clinical narrative: This is a 84y.o.male with a history of diabetes, dementia who presents sent from secondary to altered mental status with fevers. Per reports, he had an indwelling Foley catheter that was removed yesterday. After that he noted a fever of 101.7. He states he tested positive for covid around 1 month ago. He was treated with monoclonal antibodies and  since recovered. Today, he is alert and oriented ×1. He is not sure why he is in the hospital. On arrival he is afebrile. Leukocytosis of 31.6. Pro calcitonin 0.35. CT was negative for acute process but showed nonspecific white matter changes and remote left basal ganglia lacunar injuries likely related to chronic microangiopathy as well as interval right frontal lobe encephalomalacia. His CXR was negative for acute process. UA was concerning for a possible UTI. Blood cultures returned positive for gram positive cocci. Infectious disease has been consulted. He was started on cefepime/vancomycin.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Leukocytosis, Mental status changes, Microangiopathy, Procalcitonin, Pyrexia
Clinical narrative: This is a 84y.o.male with a history of diabetes, dementia who presents sent from secondary to altered mental status with fevers. Per reports, he had an indwelling Foley catheter that was removed yesterday. After that he noted a fever of 101.7. He states he tested positive for covid around 1 month ago. He was treated with monoclonal antibodies and  since recovered. Today, he is alert and oriented ×1. He is not sure why he is in the hospital. On arrival he is afebrile. Leukocytosis of 31.6. Pro calcitonin 0.35. CT was negative for acute process but showed nonspecific white matter changes and remote left basal ganglia lacunar injuries likely related to chronic microangiopathy as well as interval right frontal lobe encephalomalacia. His CXR was negative for acute process. UA was concerning for a possible UTI. Blood cultures returned positive for gram positive cocci. Infectious disease has been consulted. He was started on cefepime/vancomycin.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory syncytial virus test negative, SARS-CoV-2 test positive, White matter lesion
Clinical narrative: This is a 84y.o.male with a history of diabetes, dementia who presents sent from secondary to altered mental status with fevers. Per reports, he had an indwelling Foley catheter that was removed yesterday. After that he noted a fever of 101.7. He states he tested positive for covid around 1 month ago. He was treated with monoclonal antibodies and  since recovered. Today, he is alert and oriented ×1. He is not sure why he is in the hospital. On arrival he is afebrile. Leukocytosis of 31.6. Pro calcitonin 0.35. CT was negative for acute process but showed nonspecific white matter changes and remote left basal ganglia lacunar injuries likely related to chronic microangiopathy as well as interval right frontal lobe encephalomalacia. His CXR was negative for acute process. UA was concerning for a possible UTI. Blood cultures returned positive for gram positive cocci. Infectious disease has been consulted. He was started on cefepime/vancomycin.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bone pain, Bursa disorder, Immediate post-injection reaction, Injected limb mobility decreased
Clinical narrative: Client reports shoulder pain post 1/4/2021 vaccination.  Reports continues up to date of report 12/9/2021.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Joint injection, Magnetic resonance imaging abnormal, Product administered at inappropriate site
Clinical narrative: Client reports shoulder pain post 1/4/2021 vaccination.  Reports continues up to date of report 12/9/2021.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Bursitis, Magnetic resonance imaging abnormal
Clinical narrative: Client reports shoulder pain post 1/4/2021 vaccination.  Reports continues up to date of report 12/9/2021.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Blood test abnormal, Crying, Eye swelling, Sleep disorder
Clinical narrative: 3 days after 2nd covid vaccine pt awoke at 1 am with horrible mid sternal chest pain- he went and woke his mother up saying his heart hurt. Family brought pt to ED where vital signs were normal and pts pain had resolved. Labs were drawn and troponin was elevated to  277. EKG and Echo normal. Repeat Troponin trended down to 144 12 hours later. Pt was observed with telemetry monitoring x 24 hours with normal vital signs and then discharged home to F/U with PMD and Pediatric cardiology.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: 3 days after 2nd covid vaccine pt awoke at 1 am with horrible mid sternal chest pain- he went and woke his mother up saying his heart hurt. Family brought pt to ED where vital signs were normal and pts pain had resolved. Labs were drawn and troponin was elevated to  277. EKG and Echo normal. Repeat Troponin trended down to 144 12 hours later. Pt was observed with telemetry monitoring x 24 hours with normal vital signs and then discharged home to F/U with PMD and Pediatric cardiology.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angina pectoris, Cardiac telemetry normal, Chest pain, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: 3 days after 2nd covid vaccine pt awoke at 1 am with horrible mid sternal chest pain- he went and woke his mother up saying his heart hurt. Family brought pt to ED where vital signs were normal and pts pain had resolved. Labs were drawn and troponin was elevated to  277. EKG and Echo normal. Repeat Troponin trended down to 144 12 hours later. Pt was observed with telemetry monitoring x 24 hours with normal vital signs and then discharged home to F/U with PMD and Pediatric cardiology.
Age: 6.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test abnormal, Sleep disorder, Troponin increased
Clinical narrative: 3 days after 2nd covid vaccine pt awoke at 1 am with horrible mid sternal chest pain- he went and woke his mother up saying his heart hurt. Family brought pt to ED where vital signs were normal and pts pain had resolved. Labs were drawn and troponin was elevated to  277. EKG and Echo normal. Repeat Troponin trended down to 144 12 hours later. Pt was observed with telemetry monitoring x 24 hours with normal vital signs and then discharged home to F/U with PMD and Pediatric cardiology.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Alanine aminotransferase increased, Blood fibrinogen increased, Brain natriuretic peptide increased, C-reactive protein increased
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Fatigue, Fibrin D dimer increased, Headache, Left ventricular dysfunction
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocardial strain imaging abnormal, Serum ferritin increased, Vomiting
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Blood albumin decreased, Blood fibrinogen increased, C-reactive protein increased, COVID-19
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Conjunctival hyperaemia, Echocardiogram abnormal, Exposure to SARS-CoV-2, Fibrin D dimer increased, Headache
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Illness, Inflammation, Left ventricular dysfunction, Lymphocyte count decreased, Multisystem inflammatory syndrome in children
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count increased, Pyrexia, Rash, Red blood cell sedimentation rate increased, SARS-CoV-2 test
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Thrombocytopenia
Clinical narrative: Patient was admitted to the hospital 12/3/21-12/7/21 with MIS-C. She met the CDC's case definition for MIS-C.  1. An individual aged <21 years presenting with fever [Fever definition is >38.0°C for ?24 hours, or report of subjective fever lasting ?24 hours], laboratory evidence of inflammation, [**Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and/or low albumin] and evidence of clinically severe illness requiring hospitalization.              -In this case, the first calendar day of fever was 12/1/21.              -In this case, the evidence for inflammation was:  elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, d-dimer, ferritin, elevated neutrophils, reduced lymphocytes and low albumin            -this patient had clinically severe illness, hospitalized 12/3/21 2. In addition, the diagnosis requires >2 organ systems involvement. The evidence/type of organ system involvement are as follows:                                Hematologic thrombocytopenia   Gastrointestinal abdominal pain   Dermatologic conjunctival injection and rash   Neurological headache 3. In this case there is not an alternative plausible diagnoses.  4. In this case, the patient is positive for current or recent SARS-CoV-2 infection by: a. RT-PCR positive on 12/1/21, negative on 12/4/21 b. Serology- pending c. exposure to a suspected or confirmed COVID-19 case within the 4 weeks prior to the onset of symptoms. Family had COVID 1 month ago.   She was treated with Prednisone x 7 days with a good response to treatment.
Age: 26.0
Sex: M
Vaccine: COVID19, FLU4, COVID19, UNK
Symptoms: Autopsy, Fatigue, Myalgia, Oropharyngeal pain, Tachycardia
Clinical narrative: Patient received his vaccine on Monday, this was his Pfizer booster shot. He had no side effects from the first two vaccines. There were no side effects from the booster and influenza vaccine until Thursday when he went to work and then needed to go home sick due to fatigue, muscle soreness and sore throat. He slept most of the day. On Friday 11/12, he stayed home from work with the same symptoms. His mother was with him from 1-4 and he was up ambulating and had lunch with her. At 2 PM he had a mild fever of 100.2 with a blood pressure of 134/79 and heart rate 112 with 94% oxygenation.  At 4PM his fever went down to 98.3 with 112 heart rate and 100% oxygenation. His father ate dinner with him from 5-6 and he had a normal appetite and was walking around. He said he was going to rest and play video games at 6 PM. He continued to engage with friends via text message until 7:48 PM. Around 8PM he took 76 steps to use the bathroom and take a dose of Benadryl to sleep well. His mother texted him at 9PM to check in and patient did not respond, and she assumed he had gone to bed. On the 13th when he had not replied by 7:30 in the morning patient's mother and father went to his apartment and discovered him deceased. He was found in his recliner with his phone on one thigh and remote control on the other and no signs of distress. He had never been sick enough to go back to bed on the 12th. In review of his watch his family was able to determine when his last heartbeat was tracked and the last steps he took around 8 PM. The coroners reported final diagnosis is: FINAL DIAGNOSIS I. Multifocal myocarditis involving the cardiac left ventricle and interventricular septum A. Received Pfizer Covid booster shot and flu shot on 11/8/2021 B. Pulmonary congestion C. Splenomegaly D. Cerebral edema II. Right cardiac ventricle dilation Ill. Vein of Galen malformation, clinical A. Multiple vessels of varying size with refractile foreign material with giant cell inflammatory response and calcification; large caliber vessel with thrombus CAUSE OF DEATH: Multifocal myocarditis involving the left ventricle and septum CONTRIBUTORY: Recent Pfizer Covid booster vaccine MANNER OF DEATH: Natural COMMENT: Myocarditis following administration of Pfizer Covid vaccine has been noted in male patients between the ages of 16 and 29 years, and most commonly presents 3 to 5 days following administration. Post Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction. Please see the attached full coroner's report on later pages in this pdf.
Age: 26.0
Sex: M
Vaccine: COVID19, FLU4, COVID19, UNK
Symptoms: Autopsy, Brain oedema, Condition aggravated, Death, Fatigue
Clinical narrative: Patient received his vaccine on Monday, this was his Pfizer booster shot. He had no side effects from the first two vaccines. There were no side effects from the booster and influenza vaccine until Thursday when he went to work and then needed to go home sick due to fatigue, muscle soreness and sore throat. He slept most of the day. On Friday 11/12, he stayed home from work with the same symptoms. His mother was with him from 1-4 and he was up ambulating and had lunch with her. At 2 PM he had a mild fever of 100.2 with a blood pressure of 134/79 and heart rate 112 with 94% oxygenation.  At 4PM his fever went down to 98.3 with 112 heart rate and 100% oxygenation. His father ate dinner with him from 5-6 and he had a normal appetite and was walking around. He said he was going to rest and play video games at 6 PM. He continued to engage with friends via text message until 7:48 PM. Around 8PM he took 76 steps to use the bathroom and take a dose of Benadryl to sleep well. His mother texted him at 9PM to check in and patient did not respond, and she assumed he had gone to bed. On the 13th when he had not replied by 7:30 in the morning patient's mother and father went to his apartment and discovered him deceased. He was found in his recliner with his phone on one thigh and remote control on the other and no signs of distress. He had never been sick enough to go back to bed on the 12th. In review of his watch his family was able to determine when his last heartbeat was tracked and the last steps he took around 8 PM. The coroners reported final diagnosis is: FINAL DIAGNOSIS I. Multifocal myocarditis involving the cardiac left ventricle and interventricular septum A. Received Pfizer Covid booster shot and flu shot on 11/8/2021 B. Pulmonary congestion C. Splenomegaly D. Cerebral edema II. Right cardiac ventricle dilation Ill. Vein of Galen malformation, clinical A. Multiple vessels of varying size with refractile foreign material with giant cell inflammatory response and calcification; large caliber vessel with thrombus CAUSE OF DEATH: Multifocal myocarditis involving the left ventricle and septum CONTRIBUTORY: Recent Pfizer Covid booster vaccine MANNER OF DEATH: Natural COMMENT: Myocarditis following administration of Pfizer Covid vaccine has been noted in male patients between the ages of 16 and 29 years, and most commonly presents 3 to 5 days following administration. Post Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction. Please see the attached full coroner's report on later pages in this pdf.
Age: 26.0
Sex: M
Vaccine: COVID19, FLU4, COVID19, UNK
Symptoms: Giant cell arteritis, Hypersomnia, Impaired work ability, Inflammation, Malaise
Clinical narrative: Patient received his vaccine on Monday, this was his Pfizer booster shot. He had no side effects from the first two vaccines. There were no side effects from the booster and influenza vaccine until Thursday when he went to work and then needed to go home sick due to fatigue, muscle soreness and sore throat. He slept most of the day. On Friday 11/12, he stayed home from work with the same symptoms. His mother was with him from 1-4 and he was up ambulating and had lunch with her. At 2 PM he had a mild fever of 100.2 with a blood pressure of 134/79 and heart rate 112 with 94% oxygenation.  At 4PM his fever went down to 98.3 with 112 heart rate and 100% oxygenation. His father ate dinner with him from 5-6 and he had a normal appetite and was walking around. He said he was going to rest and play video games at 6 PM. He continued to engage with friends via text message until 7:48 PM. Around 8PM he took 76 steps to use the bathroom and take a dose of Benadryl to sleep well. His mother texted him at 9PM to check in and patient did not respond, and she assumed he had gone to bed. On the 13th when he had not replied by 7:30 in the morning patient's mother and father went to his apartment and discovered him deceased. He was found in his recliner with his phone on one thigh and remote control on the other and no signs of distress. He had never been sick enough to go back to bed on the 12th. In review of his watch his family was able to determine when his last heartbeat was tracked and the last steps he took around 8 PM. The coroners reported final diagnosis is: FINAL DIAGNOSIS I. Multifocal myocarditis involving the cardiac left ventricle and interventricular septum A. Received Pfizer Covid booster shot and flu shot on 11/8/2021 B. Pulmonary congestion C. Splenomegaly D. Cerebral edema II. Right cardiac ventricle dilation Ill. Vein of Galen malformation, clinical A. Multiple vessels of varying size with refractile foreign material with giant cell inflammatory response and calcification; large caliber vessel with thrombus CAUSE OF DEATH: Multifocal myocarditis involving the left ventricle and septum CONTRIBUTORY: Recent Pfizer Covid booster vaccine MANNER OF DEATH: Natural COMMENT: Myocarditis following administration of Pfizer Covid vaccine has been noted in male patients between the ages of 16 and 29 years, and most commonly presents 3 to 5 days following administration. Post Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction. Please see the attached full coroner's report on later pages in this pdf.
Age: 26.0
Sex: M
Vaccine: COVID19, FLU4, COVID19, UNK
Symptoms: Myalgia, Myocarditis, Oropharyngeal pain, Pathology test, Pulmonary congestion
Clinical narrative: Patient received his vaccine on Monday, this was his Pfizer booster shot. He had no side effects from the first two vaccines. There were no side effects from the booster and influenza vaccine until Thursday when he went to work and then needed to go home sick due to fatigue, muscle soreness and sore throat. He slept most of the day. On Friday 11/12, he stayed home from work with the same symptoms. His mother was with him from 1-4 and he was up ambulating and had lunch with her. At 2 PM he had a mild fever of 100.2 with a blood pressure of 134/79 and heart rate 112 with 94% oxygenation.  At 4PM his fever went down to 98.3 with 112 heart rate and 100% oxygenation. His father ate dinner with him from 5-6 and he had a normal appetite and was walking around. He said he was going to rest and play video games at 6 PM. He continued to engage with friends via text message until 7:48 PM. Around 8PM he took 76 steps to use the bathroom and take a dose of Benadryl to sleep well. His mother texted him at 9PM to check in and patient did not respond, and she assumed he had gone to bed. On the 13th when he had not replied by 7:30 in the morning patient's mother and father went to his apartment and discovered him deceased. He was found in his recliner with his phone on one thigh and remote control on the other and no signs of distress. He had never been sick enough to go back to bed on the 12th. In review of his watch his family was able to determine when his last heartbeat was tracked and the last steps he took around 8 PM. The coroners reported final diagnosis is: FINAL DIAGNOSIS I. Multifocal myocarditis involving the cardiac left ventricle and interventricular septum A. Received Pfizer Covid booster shot and flu shot on 11/8/2021 B. Pulmonary congestion C. Splenomegaly D. Cerebral edema II. Right cardiac ventricle dilation Ill. Vein of Galen malformation, clinical A. Multiple vessels of varying size with refractile foreign material with giant cell inflammatory response and calcification; large caliber vessel with thrombus CAUSE OF DEATH: Multifocal myocarditis involving the left ventricle and septum CONTRIBUTORY: Recent Pfizer Covid booster vaccine MANNER OF DEATH: Natural COMMENT: Myocarditis following administration of Pfizer Covid vaccine has been noted in male patients between the ages of 16 and 29 years, and most commonly presents 3 to 5 days following administration. Post Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction. Please see the attached full coroner's report on later pages in this pdf.
Age: 26.0
Sex: M
Vaccine: COVID19, FLU4, COVID19, UNK
Symptoms: Right ventricular dilatation, Splenomegaly, Thrombosis, Vascular calcification, Vein of Galen aneurysmal malformation
Clinical narrative: Patient received his vaccine on Monday, this was his Pfizer booster shot. He had no side effects from the first two vaccines. There were no side effects from the booster and influenza vaccine until Thursday when he went to work and then needed to go home sick due to fatigue, muscle soreness and sore throat. He slept most of the day. On Friday 11/12, he stayed home from work with the same symptoms. His mother was with him from 1-4 and he was up ambulating and had lunch with her. At 2 PM he had a mild fever of 100.2 with a blood pressure of 134/79 and heart rate 112 with 94% oxygenation.  At 4PM his fever went down to 98.3 with 112 heart rate and 100% oxygenation. His father ate dinner with him from 5-6 and he had a normal appetite and was walking around. He said he was going to rest and play video games at 6 PM. He continued to engage with friends via text message until 7:48 PM. Around 8PM he took 76 steps to use the bathroom and take a dose of Benadryl to sleep well. His mother texted him at 9PM to check in and patient did not respond, and she assumed he had gone to bed. On the 13th when he had not replied by 7:30 in the morning patient's mother and father went to his apartment and discovered him deceased. He was found in his recliner with his phone on one thigh and remote control on the other and no signs of distress. He had never been sick enough to go back to bed on the 12th. In review of his watch his family was able to determine when his last heartbeat was tracked and the last steps he took around 8 PM. The coroners reported final diagnosis is: FINAL DIAGNOSIS I. Multifocal myocarditis involving the cardiac left ventricle and interventricular septum A. Received Pfizer Covid booster shot and flu shot on 11/8/2021 B. Pulmonary congestion C. Splenomegaly D. Cerebral edema II. Right cardiac ventricle dilation Ill. Vein of Galen malformation, clinical A. Multiple vessels of varying size with refractile foreign material with giant cell inflammatory response and calcification; large caliber vessel with thrombus CAUSE OF DEATH: Multifocal myocarditis involving the left ventricle and septum CONTRIBUTORY: Recent Pfizer Covid booster vaccine MANNER OF DEATH: Natural COMMENT: Myocarditis following administration of Pfizer Covid vaccine has been noted in male patients between the ages of 16 and 29 years, and most commonly presents 3 to 5 days following administration. Post Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction. Please see the attached full coroner's report on later pages in this pdf.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: She started having symptoms of couch and shortness of breath 6 days before presentation on 12/9/2021. She is progressively worsened.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Dizziness, Electrocardiogram, Extrasystoles, Ventricular extrasystoles
Clinical narrative: Pt states 3 days post vaccine he developed mental fog and felt flu like. Then 9 days post vaccine pt started experiencing PVC's. Pt states this has occurred several times since then.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Feeling abnormal, Influenza like illness, Ventricular extrasystoles
Clinical narrative: Pt states 3 days post vaccine he developed mental fog and felt flu like. Then 9 days post vaccine pt started experiencing PVC's. Pt states this has occurred several times since then.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Hypoaesthesia, Joint swelling, Loss of personal independence in daily activities, Pain in extremity
Clinical narrative: 48 hours after vaccine, patient developed rash on b/l thighs which expanded to iclude torso, hands.  Hands became swollen, numb.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Peripheral swelling, Rash, Sleep disorder
Clinical narrative: 48 hours after vaccine, patient developed rash on b/l thighs which expanded to iclude torso, hands.  Hands became swollen, numb.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Peripheral swelling, Rash
Clinical narrative: 48 hours after vaccine, patient developed rash on b/l thighs which expanded to iclude torso, hands.  Hands became swollen, numb.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AEs or PQC reported; expired MMR II administered to patient; This spontaneous report was received from a consumer referring to a 2-year-old male patient. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.      On 15-NOV-2021, the patient was vaccinated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # S035356, expiration date 05-NOV-2021; strength, dose, route of administration, anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AEs) or product quality complaint (PQC) was reported.
Sex: U
Vaccine: HEPA
Symptoms: Product storage error
Clinical narrative: VAQTA was administered after a temperature excursion; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were not reported.      On 30-NOV-2021, the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) which was after a temperature excursion (0.5 milliliter, lot # T031202, expiration date 14-JUN-2022, route was not reported) for prophylaxis (Product storage error).    Administered dose of vaccine experienced the temperature excursion of 14.1 degrees Celsius  for 14 hours. There were no previous excursions.  This is one of the two reports from the same reporter.
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE; Medical assistant called and reported that dose of M-M-R II expired on 29-JUL-2018 and was administered on 14-AUG-2018; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, historical drugs, allergies, concurrent conditions and concomitant therapies were not provided.   On 14-AUG-2018, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rha), lot # M034856 and expiration date since it made matches with the autopopulated expiration date: 29-JUL-2018, (dose, frequency, route of administration and indication was not provided). No additional adverse event was reported.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: shingles; I have shingles for the second time, even though I was vaccinated; This spontaneous report was received from a consumer referring to themselves, a patient of unknown age. Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.      On an unknown date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for prophylaxis (strength, dose, frequency, route of administration, lot number and expiration date were not reported).         On an unknown date, the patient got shingles for the second time, even though they were vaccinated (herpes zoster and vaccination failure). The outcome of herpes zoster and vaccination failure was unknown.     The causal relationship of the events with zoster vaccine live (ZOSTAVAX) was not reported.  Upon internal review, vaccination failure was considered to be related to Zoster Vaccine Live (ZOSTAVAX).
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: no other AE occurred; VARlVAX was administered after a temperature excursion; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported.  On 07-DEC-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose after a temperature excursion for prophylaxis (lot # U019904, expiration date 24-JUN-2023; strength and route were not reported). Vaccine was stored at 36 F for 46 hours (product storage error). There was no previous temperature excursion. It was confirmed that no other adverse event (AE) occurred.
Age: 29.0
Sex: F
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No additional adverse event reported; first dose in January 2020, second dose in November 2021; This spontaneous report was received from the patient's brother referring to a 30 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  In "January 2020", the patient received the first shot of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) but due to Covid protocols her doctor's office pushed back vaccine appointments. For this reason, the patient received her second shot of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) the "last month" in November 2021. The patient's shot was almost one year late. No additional adverse event information reported. No product quality complaint involved.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional adverse event; One dose of Proquad was administered after a temperature excursion; This spontaneous report was received from a medical assistant, and refers to a patient of unknown age and gender.  The information about patient's concurrent condition, medical and drug history and concomitant medications was unknown.  On 21-NOV-2021, the patient was vaccinated with one dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # U010743 and expiration date: 03-OCT-2022, dose: 0.5 milliliter (route of administration and anatomical location were not provided) as prophylaxis.  On an unspecified date in November 2021, the administered doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD)  had a temperature excursion (product storage error) as follows: -14°C to -10°C lasted for 45 minutes and -10°C to 8°C (-9.92°C) lasted for 15 minutes. No previous temperature excursion and no additional adverse event reported.
Sex: U
Vaccine: VARZOS
Symptoms: Anxiety
Clinical narrative: Thought I was dying; This case was reported by a consumer via interactive digital media and described the occurrence of impending doom in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced impending doom. On an unknown date, the outcome of the impending doom was unknown.   It was unknown if the reporter considered the impending doom to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingles vaccine and thought he/she was dying.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: whole body was sore; This case was reported by a consumer and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced general body pain. On an unknown date, the outcome of the general body pain was recovered/resolved.   It was unknown if the reporter considered the general body pain to be related to Shingles vaccine.  Additional details were provided are as follows: The age at vaccination was not reported. The patient got a shot of Shingles vaccines so far and it was not painful but his/her whole body was sore for nearly 2 days. The patient stated Covid vaccine only made him/her tired and also stated that they were just different. The follow-up could not be possible as no contact details were available.
Age: 56.0
Sex: U
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Have fever now 100.7; This case was reported by a consumer via call center representative and described the occurrence of fever in a 56-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included MODERNA VACCINE (already had moderna shots and booster on an unknown date).   On 7th December 2021, the patient received Shingles vaccine. On 7th December 2021, less than a day after receiving Shingles vaccine, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The patient already had moderna shots and booster. The patient received a dose of Shingles vaccine a day before reporting and had fever 100.7 degree in afternoon. The reporter consented to follow-up.
Sex: U
Vaccine: VARZOS
Symptoms: Illness
Clinical narrative: Emergency room really sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported this case. The age at vaccination was not reported. The patient reported that the shingles vaccine sent him/her to the emergency room, was really sick. The follow-up would not possible as no contact details were available.